$69.75 +1.10 (1.60%) bluebird bio Inc - NASDAQ

Dec. 2, 2016 | 04:00 PM

Quotes

  1. Quotes

  2. Charts

  3. Analysis

  4. Options

  5. Historical



Last Trade: 69.75
Trade Time: Dec 02 04:00 PM Eastern Daylight Time
Change: +1.10 (1.60%)
Prev Close: 68.65
Open: 68.40
Bid: 69.75
Ask: 69.80
  1. Bluebird Rockets On Myeloma Drug; Celgene Gets Boost

    Investors Business Daily | Dec. 1, 2016 | 12:10PM EST
  2. Bluebird Bio, Celgene Multiple Myeloma Therapy Shines In 9-Patient Study

    Investors Business Daily | Nov. 30, 2016 | 18:58PM EST
  3. Swing Trading Watch List - Tuesday, November 29

    TalkMarkets | Nov. 29, 2016 | 23:59PM EST
  4. Market Reversal In Biotech But Healthcare Stocks Are Still Muddled

    TalkMarkets | Nov. 29, 2016 | 22:56PM EST
  5. Piper Sees Bluebird Regaining 'Mojo And Momentum'

    TalkMarkets | Nov. 29, 2016 | 08:15AM EST
  6. Five Biotech IPOs Lead The Way In 2016

    TalkMarkets | Nov. 25, 2016 | 10:33AM EST
  7. Calithera Pharma In Focus Part 1 - Checkpoint Inhibition

    TalkMarkets | Nov. 16, 2016 | 07:21AM EST
  8. Biotech Bear Market Looking For Relief From Q3 Large Cap Growth

    TalkMarkets | Oct. 26, 2016 | 20:45PM EST
  9. Analysts diverge on bluebird bio after investor day

    TalkMarkets | Oct. 14, 2016 | 17:58PM EST
  10. Biotech Stocks Recovering From Last Week’s Free Fall

    TalkMarkets | Oct. 5, 2016 | 23:06PM EST
  11. Rayno 2016 Life Science Portfolio Update

    TalkMarkets | Sep. 29, 2016 | 20:14PM EST
  12. Biotech Stocks Pause At Resistance: IBB

    TalkMarkets | Sep. 26, 2016 | 23:20PM EST
  13. Biotech ETFs Lead Q3 Rally: XBI Breaks Out

    TalkMarkets | Sep. 22, 2016 | 20:00PM EST
  14. Bluebird Bio Starts First CAR-T Cancer Trial; Juno Gets An Upgrade

    IBD | Feb. 17, 2016 | 14:28PM EST
  15. Bluebird Bio Gains 9% After Co. Begins New Phase 1 Study

    Benzinga | Feb. 17, 2016 | 12:52PM EST
Trading Center